Identification
Instrument name
Genfit
Symbol
GNFT
ISIN code
FR0004163111
Exchange / Market
Euronext
Trading location
Paris
Products family
Stocks
Capitalization compartment
Compartment B
ICB
Biotechnology
Activity description

<div class="detail">
Genfit is a leading European biopharmaceutical group. It specializes in the discovery and development of drugs for preventing and treating risk factors related to cardiometabolic pathologies (atherosclerosis, dyslipidemias, hypertension, diabetes, obesity, etc.) and inflammatory diseases.Genfit&#39;s development model, which allies internally financed research programs with partner-supported programs, allows it to manage the associated risks while generating value for its shareholders. Working both on its own behalf and for large industrial pharmaceutical group accounts, Genfit has developed a rich and diversified portfolio of promising drugs in the clinical and pre-clinical development phases.<br />
<em>Source : Cofisem</em></div>

Website address
Operation
IPO date
IPO type
Transfer
Transfer details
Alternext - Euronext